Evaluation of leuprolide acetate treatment on histopathology of uterine myomata

Fertil Steril. 1994 Apr;61(4):622-6.

Abstract

Objective: To determine if short-term, preoperative leuprolide acetate (LA) therapy alters the histologic appearance of uterine leiomyomata.

Design: Retrospective evaluation by a pathologist (who was blinded to patient history) of the histologic features of leiomyomata excised from 36 women, 12 who received preoperative LA and 24 age-matched controls.

Setting: Yale-New Haven Hospital, New Haven, Connecticut, from September 1989 to September 1990.

Main outcome measure: The histologic specimens were evaluated for the presence of mitotic activity, cellular atypia, cellularity, and secondary changes including edema, fibrosis, calcification, hemorrhage, infarction, hyalinization, and vascular appearance.

Results: Of the 12 patients treated with LA, 10 (84%) demonstrated a reduction in uterine volume after 3 to 6 months of LA therapy. There was no difference in any of the histopathologic parameters evaluated between the LA-treated group and the untreated group. Exclusion of leiomyoma, which did not have a reduction in size during LA therapy, did not alter the analysis. Among patients treated with LA, those leiomyoma that did not respond to LA had a greater degree of hyalinization than those that responded.

Conclusion: Reduction in uterine size by short-term LA therapy did not detectably alter histologic appearance of leiomyoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Humans
  • Leiomyoma / drug therapy
  • Leiomyoma / pathology*
  • Leiomyoma / surgery
  • Leuprolide / therapeutic use*
  • Retrospective Studies
  • Uterine Neoplasms / drug therapy
  • Uterine Neoplasms / pathology*
  • Uterine Neoplasms / surgery
  • Uterus / pathology

Substances

  • Leuprolide